Significant healing 3-4 weeks
Cagrilintide is developed by Novo Nordisk, the same company behind semaglutide (Ozempic/Wegovy) and the CagriSema combination
Regarding neovascularization, a key process for supplying blood to the healing tissue, the number of blood vessels tended to increase from day 7 to day 21 in all groups
2: The volume of plasma (blood cells) is diluted by one time

WATER, METHYLPROPANEDIOL, GLYCERIN, BETA-GLUCAN, DIMETHICONE, NIACINAMIDE, CYCLOPENTASILOXANE, BETAINE, POLYGLYCERIN-3, ALGAE EXTRACT, ECLIPTA LEAF EXTRACT, CENTELLA EXTRACT, FIG FRUIT EXTRACT, LICORICE EXTRACT, PANAX GINSENG EXTRACT, ULMUS DAVIDIANA EXTRACT, CAUDATUS SEED EXTRACT, LECITHIN, KERNEL OIL, SODIUM ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER, SODIUM POLYACRYLATE, ETHYLHEXYL STEARATE, ISOHEXADECANE, PANTHENOL, DIMETHICONOL, BUTYLENE GLYCOL, GLUTATHIONE (1000PPM), RICE FERMENT, SORBITAN OLEATE, TRIETHOXYCAPRYLYLSILANE, TRIDECETH-6, SQUALANE, FRUCTOOLIGOSACCHARIDES, HYDROGENATED POLYSOBUTENE, DISODIUM EDTA, ISONONYL ISONONANOATE, POLYGLYCERYL-10 STEARATE, CETEARYL ALCOHOL, STEARIC ACID, SHEA BUTTER, POLYGLYCERYL-2 DIPOLYHYDROXYSTEARATE, HYALURONIC ACID, INULIN LAURYL CARBAMATE, PEARL POWDER, CARBOMER, CERAMIDE NP, DISODIUM STEAROYL GLUTAMATE, PALMITOYL PENTAPEPTIDE-4, POLYSORBATE 80, POLYSORBATE 20, FRANGRANCE, 1,2-HEXANEDIOL, HYDROXYACETOPHENONE, TITANIUM DIOXIDE (CI 77891) *** Ingredients are subject to change at the manufacturer's discretion
